Skye Bioscience Inc expected to post a loss of 25 cents a share - Earnings Preview

Skye Bioscience

06/11/2024 14:35

* Skye Bioscience Inc  SKYE.OQ   SKYE.O  is expected
to report
resultson November 7 for the period ending September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Skye Bioscience Inc is
for a
loss of 25 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Skye
Bioscience
Inc is $19.00​, above​ its last closing price of $5.35. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jun. 30 2024  -0.21       -0.19      -0.20     Missed  -2.6
 Mar. 31 2024  -0.16       -0.16      -0.18     Missed  -12.5
 Dec. 31 2023  -0.38       -0.38      -0.63     Missed  -65.8​
 ​​                                                     
                                                        ​
 This summary was machine generated November 6 at 14:35 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)